Biofluid Technology, Inc.

Kdl Technologies, Inc.

Reuben E Kron

Stephen Joseph Kron

Mitchell Litt

Provided are apparatuses and methods for rapid viscometry of whole blood, plasma, and/or whole blood during coagulation. The disclosed technology measures the blood viscosity through the full range of flow rates found in the cardio-vascular system. This in vitro test can be performed on fresh or anticoagulated whole blood to predict the flow properties (e.g., viscosity) anywhere in the body from the aorta to the deep veins of the leg. The result is a flow-rate dependent blood viscosity curve (viscosity profile) that helps the clinician predict and manage the patient's vulnerability to thrombosis and embolism, which is of particular relevance to COVID-19 patients and/or ICU patients.

Rapid profile viscometer devices and methods

Provided are devices and methods suitable for immobilizing tissue and for use in non-invasive methods of assessing lower urinary tract symptoms as well as in surgical application.

Devices and methods for tissue immobilization and non-invasive lower urinary tract analysis

Surgical tissue stabilizers and related methods

A clinical whole blood viscometer and a method for obtaining instantaneous whole blood viscosity measurements over a wide range of shear rates with a single blood sample is described. A conventionally acquired sample of fresh blood is drawn from a patient and introduced into the viscometer so as to establish viscous flow, the viscosity measurements being taken by remote sensing devices activated by compliant solids or gases in contact with the sample.

Growing community of inventors

Bryn Mawr, PA, United States of America

Reuben E Kron